DCGI warns of stern action against cos which change contents of formulations without changing existing brand names
The Drugs Controller General of India (DCGI) has warned of stern action against those manufacturers and marketers of pharmaceutical formulations who change the contents of the formulations without changing the existing brand names. In a circular, the national drug regulator has directed the state drug controllers and the zonal & sub-zonal officers of the Central Drugs Standard Control Organisation (CDSCO) to consider legal measures to discourage the unethical practice of marketing formulations by changing their contents without changing the existing brand names by the pharma companies. The DCGI wants the enforcement officers and drug controllers to ensure that contents changed formulations are not marketed in the country in the old brand names as it confuses both the prescribers and patients. He wanted the licensing authorities not to permit to sell formulations with changed compositions without changing the old brand names. In the circular sent to all central...